A dermatologist’s examination, even with the help of a dermoscope, has limitations.
Often we identify a suspicious lesion whose nature is unclear, and in the past the only real option was a surgical biopsy, with everything that implies: an incision, pain and a scar in the area.
With an LC-OCT system we can now scan the lesion layer by layer, without cutting the skin.
This way the decision about further treatment is based on richer information and less guesswork. In many cases a cut can be avoided altogether, and if treatment is still needed, it can be performed using non-invasive methods.
CE marking in Europe · FDA clearance in the USA · Used in more than 14 countries · Supported by more than 240 clinical studies
Virtual biopsy, in plain language
deepLive™ is an advanced imaging device that works with LC-OCT technology. It produces three-dimensional images of the skin layers at cellular resolution, directly on the skin and without taking tissue. The system switches in real time between a horizontal image and a vertical image resembling what is seen in the laboratory, and builds a three-dimensional image of the lesion from them. That is why the test is called a “virtual biopsy”: the information about the lesion’s structure comes from light, not from cutting, and is also processed by an artificial intelligence system.
At our center the test is a tool that assists the dermatologist in diagnosis. It is mainly suitable for lesions that are not clear-cut, especially lesions in sensitive areas such as the face, or when basal cell carcinoma (BCC) is suspected. It also helps in evaluating other types of skin cancer. The medical decision is always made by the physician, based on the full picture.
And what is the difference from dermoscopy?
Dermoscopy magnifies what is seen on the surface of the skin. The LC-OCT system lets us see inside the skin, at a resolution that makes every cell visible.
The examination focuses on one lesion. For the whole body, we offer computerized mole mapping.
About 97% sensitivity and 90% specificity for diagnosing BCC and other skin tumors
In unclear cases, or when a deep tumor is found, we proceed to a surgical biopsy
Suitability is determined by the physician after an examination. Not every lesion is suitable for an optical examination.
Here you will find answers to the questions most often asked about deepLive™ optical biopsy at the On.Top center. If you are missing information, you are welcome to contact us.
It is an imaging examination that shows the layers of the skin beneath the surface, at cellular resolution, without cutting and without taking tissue.
Often yes, but not always. It helps us decide when a sample is truly needed. When there is a medical reason, we will recommend a surgical biopsy.
The imaging findings are seen already during the visit, and we explain them to you on the spot.
Mole mapping documents the skin surface of the entire body over time. The LC-OCT examination focuses on a specific lesion and looks in depth. They are complementary tools, and sometimes we will recommend both.
Mainly for suspicious skin lesions that are not clear-cut, especially when BCC is suspected. Suitability is determined at the examination.
The examination itself does not cut the skin, and therefore leaves no scar. If we decide together that a biopsy is needed, we will explain in advance what to expect.
No. It is an optical examination only
The LC-OCT examination is considered a diagnostic examination. Patients whose insurance policy includes a clause for “diagnostic examinations”, without a specific definition of the covered examinations, may receive reimbursement of up to 80% of the cost of the examination, subject to the terms of the policy.
We will explain the findings and recommend further work-up and treatment. In many cases a non-invasive or minimally invasive treatment is sufficient, such as an ointment, laser, ultrasound or freezing. In some cases a surgical biopsy will be needed, and we can perform that here at the center as well. If an oncological consultation is also required, it will take place in the same place.
The aim is to cover 100% of the facial area, but in practice full coverage cannot be guaranteed. Therefore new BCC lesions may appear later, and the examination is not hermetic. We recommend continuing regular follow-up and coming in for an examination when a change appears in the skin.
